Yu Jigui, Briles David E, Englund Janet A, Hollingshead Susan K, Glezen W Paul, Nahm Moon H
Department of Pathology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
J Infect Dis. 2003 Mar 15;187(6):1019-23. doi: 10.1086/368200. Epub 2003 Mar 6.
Currently available pneumococcal vaccines were examined for contamination by pneumococcal surface protein A (PspA) and pneumococcal surface adhesin A (PsaA). PspA could be detected in some (but not all) lots of 23-valent polysaccharide vaccine. Many lots of pneumococcal vaccines, including the heptavalent conjugate vaccine, were found to elicit small (but variable) antibody responses to PspA, PsaA, or both. The degree of contamination was highly variable, and this should be considered in pneumococcal vaccine evaluations or when capsular polysaccharide is used for pneumococcal antibody assays.
对目前可用的肺炎球菌疫苗进行了检测,以确定是否受到肺炎球菌表面蛋白A(PspA)和肺炎球菌表面黏附素A(PsaA)的污染。在部分(但并非全部)23价多糖疫苗批次中可检测到PspA。许多肺炎球菌疫苗批次,包括七价结合疫苗,被发现对PspA、PsaA或两者均产生微弱(但各不相同)的抗体反应。污染程度差异很大,在肺炎球菌疫苗评估或使用荚膜多糖进行肺炎球菌抗体检测时应考虑到这一点。